國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Translational pancreatic cancer rese...

Michalski, Christoph W.

Translational pancreatic cancer researchfrom understanding of mechanisms to novel clinical trials /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Translational pancreatic cancer researchedited by Christoph W. Michalski ... [et al.].
其他題名:	from understanding of mechanisms to novel clinical trials /
其他作者:	Michalski, Christoph W.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	xii, 245 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	PancreasCancer
電子資源:	https://doi.org/10.1007/978-3-030-49476-6
ISBN:	9783030494766$q(electronic bk.)

Translational pancreatic cancer researchfrom understanding of mechanisms to novel clinical trials /
Translational pancreatic cancer researchfrom understanding of mechanisms to novel clinical trials /[electronic resource] :edited by Christoph W. Michalski ... [et al.]. - Cham :Springer International Publishing :2020. - xii, 245 p. :ill., digital ;24 cm. - Molecular and translational medicine,2197-7852. - Molecular and translational medicine..

Subtypes of Pancreatic Adenocarcinoma -- Surveillance and Intervention in IPMN -- Novel Biomarkers of Invasive IPMN -- Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for protein biomarkers -- Metabolic Biomarkers of Pancreatic Cancer -- Blood-Based Circulating RNAs as Preventive, Diagnostic, Prognostic and Drugable Biomarkers for Pancreatic Ductal Adenocarcinoma -- Circulating tumor DNA as a novel biomarker for pancreatic cancer -- PDAC Subtypes/Stratification -- Circulating Tumor Cells as Biomarkers in Pancreatic Cancer -- Personalized Models of Human PDAC -- Therapeutic Targeting of Stromal Components -- Epigenetic Targeting -- Targeting Metabolism -- Targeting the Immune System in Pancreatic Cancer -- Phase I Trials in Pancreatic Cancer -- Translational Approaches in Surgical Treatment.

This book incorporates a multi-disciplinary approach to present how research results can be translated into clinical trials. The first part begins with a chapter on variants of pancreatic cancer, precursor lesions and groups of people at risk to developing the disease. There is a particular focus on intraductal papillary mucinous neoplasia as a large-scale clinical challenge in pancreatology. The next two parts focus on diagnosis, biomarkers and stratification that emphasize how various approaches to biomarker development are important as both prognostic and predictive tools. The final part consists of personalized treatment approaches that include preclinical models of pancreatic cancer and stromal, epigenetic and metabolism targeting as promising approaches to be translated into early phase clinical trials. Chapters within this part also deal with approaches that are close to being implemented in clinical practice or are already being tested in (early) clinical trials, such as those that targeting the immune systems and strategies to overcome immunotherapy resistance; phase 1 clinical trials and translational approaches in surgical treatment. Written by experts in their fields, Translational Pancreatic Cancer Research provides an outlook towards future directions by integrating information both from basic and clinical research and though demonstrating pathways to better understanding pancreatic cancer and current approaches to translating these into clinical practice.

ISBN: 9783030494766$q(electronic bk.)

Standard No.: 10.1007/978-3-030-49476-6doiSubjects--Topical Terms:

455462
Pancreas
--Cancer

LC Class. No.: RC280.P25 / T736 2020

Dewey Class. No.: 616.99437

Translational pancreatic cancer researchfrom understanding of mechanisms to novel clinical trials /
LDR:03433nmm a2200337 a 4500 001 583786
003 DE-He213
005 20201124091756.0
006 m d
007 cr nn 008maaau
008 210202s2020 sz s 0 eng d
020 $a 9783030494766$q(electronic bk.)
020 $a 9783030494759$q(paper)
024 7 $a 10.1007/978-3-030-49476-6 $2 doi
035 $a 978-3-030-49476-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.P25 $b T736 2020
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99437 $2 23
090 $a RC280.P25 $b T772 2020
245 0 0 $a Translational pancreatic cancer research $h [electronic resource] : $b from understanding of mechanisms to novel clinical trials / $c edited by Christoph W. Michalski ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2020.
300 $a xii, 245 p. : $b ill., digital ; $c 24 cm.
490 1 $a Molecular and translational medicine, $x 2197-7852
505 0 $a Subtypes of Pancreatic Adenocarcinoma -- Surveillance and Intervention in IPMN -- Novel Biomarkers of Invasive IPMN -- Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for protein biomarkers -- Metabolic Biomarkers of Pancreatic Cancer -- Blood-Based Circulating RNAs as Preventive, Diagnostic, Prognostic and Drugable Biomarkers for Pancreatic Ductal Adenocarcinoma -- Circulating tumor DNA as a novel biomarker for pancreatic cancer -- PDAC Subtypes/Stratification -- Circulating Tumor Cells as Biomarkers in Pancreatic Cancer -- Personalized Models of Human PDAC -- Therapeutic Targeting of Stromal Components -- Epigenetic Targeting -- Targeting Metabolism -- Targeting the Immune System in Pancreatic Cancer -- Phase I Trials in Pancreatic Cancer -- Translational Approaches in Surgical Treatment.
520 $a This book incorporates a multi-disciplinary approach to present how research results can be translated into clinical trials. The first part begins with a chapter on variants of pancreatic cancer, precursor lesions and groups of people at risk to developing the disease. There is a particular focus on intraductal papillary mucinous neoplasia as a large-scale clinical challenge in pancreatology. The next two parts focus on diagnosis, biomarkers and stratification that emphasize how various approaches to biomarker development are important as both prognostic and predictive tools. The final part consists of personalized treatment approaches that include preclinical models of pancreatic cancer and stromal, epigenetic and metabolism targeting as promising approaches to be translated into early phase clinical trials. Chapters within this part also deal with approaches that are close to being implemented in clinical practice or are already being tested in (early) clinical trials, such as those that targeting the immune systems and strategies to overcome immunotherapy resistance; phase 1 clinical trials and translational approaches in surgical treatment. Written by experts in their fields, Translational Pancreatic Cancer Research provides an outlook towards future directions by integrating information both from basic and clinical research and though demonstrating pathways to better understanding pancreatic cancer and current approaches to translating these into clinical practice.
650 0 $a Pancreas $x Cancer $x Research. $3 455462
650 1 4 $a Oncology. $3 195181
650 2 4 $a Pathology. $3 196513
700 1 $a Michalski, Christoph W. $3 874502
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Molecular and translational medicine. $3 560124
856 4 0 $u https://doi.org/10.1007/978-3-030-49476-6
950 $a Medicine (SpringerNature-11650)